F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer(297 views) Giacomobono S, Gallicchio R, Capacchione D, Nardelli A, Gattozzi D, Lettini G, Molinari L, Mainenti P, Cammarota A, Storto G
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 2013 Jul 12; 28(12): 1699-1705.
Istituto di Ricerca e Cura A Carattere Scientifico (IRCCS), Centro di Riferimento Oncologico di Basilicata (CROB), Rionero in Vulture, Italy
Istituto di Biostrutture e Bioimmagini, Consiglio Nazionale Delle Ricerche (CNR), Naples, Italy
University of Texas, Southwestern, Dallas, United States
Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS), Centro di Riferimento Oncologico di Basilicata (CROB), Via P. Pio 1, 85028 Rionero in Vulture, Italy
References: Chua, T.C., Liauw, W., Chu, F., Viewing metastatic colorectal cancer as a curable chronic disease (2012) Am J Clin Oncol, 35, pp. 77-80. , 22257778 10.1097/COC.0b013e3181fe444
Domati, F., Rossi, G., Benatti, P., Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life (2011) Intern Emerg Med, 6, pp. 529-535. , 21512795 10.1007/s11739-011-0590-y
Jemal, A., Tiwari, R.C., Murray, T., Cancer Statistics, 2004 (2004) CA Cancer J Clin, 54, pp. 8-29. , 14974761 10.3322/canjclin.54.1.8
Bipat, S., Niekel, M.C., Comans, E.F., Imaging modalities for the staging of patients with colorectal cancer (2012) Neth J Med, 70, pp. 26-34. , 22271811 1:STN:280:DC%2BC387ntFygsQ%3D%3D
Shen, Y.Y., Liang, J.A., Chen, Y.K., Clinical impact of F-18-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan (2006) Hepatogastroenterology, 53, pp. 348-350. , 16795969
Dias, A.R., Nahas, S.C., Camargo, E.E., Recent evidences of the use of F-18-fluorodeoxyglucose positron emission tomography in the management of colorectal cancer (2007) J Surg Educ, 64, pp. 114-119. , 17462214 10.1016/j.jsurg.2006.11.004
Lu, Y.Y., Chen, J.H., Chien, C.R., Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: A systematic review and meta-analysis (2013) Int J Colorectal Dis, , Feb 14. [Epub ahead of print]
Giorgetti, A., Sorace, O., Pisani, P., Accuracy of qualitative and semiquantitative analysis of 18FDG positron emission tomography scans in the evaluation of primary and metastatic lesions (2000) Clin Positron Imaging, 3, p. 182. , 11150785 10.1016/S1095-0397(00)00094-7
Kelley, R.K., Van Bebber, S.L., Phillips, K.A., Personalized medicine and oncology practice guidelines: A case study of contemporary biomarkers in colorectal cancer (2011) J Natl Compr Canc Netw, 9, pp. 13-25. , 21233242
Rockall, T.A., McDonald, P.J., Carcinoembryonic antigen: Its value in the follow-up of patients with colorectal cancer (1999) Int J Colorectal Dis, 14, pp. 73-77. , 10207736 10.1007/s003840050188 1:STN:280:DyaK1M3isVWnsQ%3D%3D
Brethauer, S.A., Magrino, T.J., Riffenburgh, R.H., Management of recurrent colorectal carcinoma (2002) Color Dis, 4, pp. 246-253. , 10.1046/j.1463-1318.2002.00327.x 10.1046/j.1463-1318.2002.00327.x
Even-Sapir, E., Parag, Y., Lerman, H., Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection (2004) Radiology, 232, pp. 815-822. , 10.1148/radiol.2323031065 15273334 10.1148/radiol.2323031065
Mainenti, P.P., Iodice, D., Segreto, S., Colorectal cancer and 18FDG-PET/CT: What about adding the T to the N parameter in loco-regional staging? (2011) World J Gastroenterol, 17, pp. 1427-1433. , 21472100 10.3748/wjg.v17.i11.1427
Wiggers, T., Mannaerts, G.H., Marinelli, A.W., Surgery for locally recurrent rectal cancer (2003) Colorectal Dis, 5, pp. 504-507. , 12925090 10.1046/j.1463-1318.2003.00507.x 1:STN:280: DC%2BD3szovVemsw%3D%3D
Kyoto, Y., Momose, M., Kondo, C., Ability of F-18-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations (2010) Ann Nucl Med, 24, pp. 395-401. , 20364373 10.1007/s12149-010-0372-z 1:CAS:528:DC%2BC3cXhtVertL7L
Shreve, P.D., Anzai, Y., Wahl, R.L., Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants (1999) Radiographics, 19, pp. 61-77. , 9925392 10.1148/radiographics.19.1.g99ja0761 1:STN:280: DyaK1M7it1yjsw%3D%3D
Quirce Pisano, R., Banzo Marraco, I., Jiménez-Bonilla, J.F., Potential sources of diagnostic pitfall and variants in FDG-PET/CT (2008) Rev Esp Med Nucl, 27, pp. 130-159. , 18367053 10.1157/13117196 1:STN:280:DC%2BD1c3gvFarug%3D%3D
Culverwell, A.D., Scarsbrook, A.F., Chowdhury, F.U., False-positive uptake on 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging (2011) Clin Radiol, 66, pp. 366-382. , 21356398 10.1016/j.crad.2010.12.004 1:STN:280:DC%2BC3M3isFantg%3D%3D
Shihab, O.C., Taylor, F., Bees, N., Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer (2011) Brit J Surg, 98, pp. 1798-1804. , MERCURY Study Group 21928408 10.1002/bjs.7662 1:STN:280: DC%2BC3MbksVOitw%3D%3D
Patel, U.B., Taylor, F., Blomqvist, L., Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience (2011) J Clin Oncol, 29, pp. 3753-3760. , 21876084 10.1200/JCO.2011.34.9068
Willett, C., Tepper, J.E., Cohen, A., Local failure following curative resection of colonic adenocarcinoma (1984) Int J Radiat Oncol Biol Phys, 10, pp. 645-651. , 6735753 10.1016/0360-3016(84)90295-5 1:STN:280:DyaL2c3jvFWhtg%3D%3D
Pilipshen, S.J., Heilweil, M., Quan, S.H., Patterns of pelvic recurrence following definitive resections of rectal cancer (1984) Cancer, 53, pp. 1354-1362. , 6692324 10.1002/1097-0142(19840315)53:6<1354: AID-CNCR2820530623>
3. 0.CO
2-J 1:STN:280:DyaL2c7gs1ersA%3D%3D
Read, T.E., Mutch, M.G., Chang, B.W., Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon (2002) J Am Coll Surg, 195, pp. 33-40. , 12113543 10.1016/S1072-7515(02)01224-3
Hasegawa, J., Nishimura, J., Yamamoto, S., Exfoliated malignant cells at the anastomosis site in colon cancer surgery: The impact of surgical bowel occlusion and intraluminal cleaning (2011) Int J Colorectal Dis, 26, pp. 875-880. , 21302117 10.1007/s00384-011-1148-1
Petersen, S., Freitag, M., Hellmich, G., Anastomotic leakage: Impact on local recurrence and survival in surgery of colorectal cancer (1998) Int J Colorectal Dis, 13, pp. 160-163. , 9810519 10.1007/s003840050158 1:STN:280:DyaK1M%2FivVaitg%3D%3D
Flanagan, F.L., Dehdashti, F., Ogunbiyi, O.A., Utility of FDGPET for investigating unexplained plasma CEA elevation in patients with colorectal cancer (1998) Ann Surg, 227, pp. 319-323. , 9527052 10.1097/00000658-199803000-00001 1:STN:280:DyaK1c7os1arsw%3D%3D
Maldonado, A., Sancho, F., Cerdan, J., FDG-PET in the detection of recurrence in colorectal cancer based on rising CEA level. Experience in 72 patients (2000) Clin Positron Imaging, 3, p. 170. , 11150773 10.1016/S1095-0397(00)00082-0
Flamen, P., Hoekstra, O.S., Homans, F., Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: The utility of positron emission tomography (PET) (2001) Eur J Cancer, 37, pp. 862-869. , 11313174 10.1016/S0959-8049(01)00049-1 1:CAS:528:DC%2BD3MXislGhtbw%3D
Libutti, S.K., Alexander, Jr.H.R., Choyke, P., A prospective study of 2-[F-18] fluoro-2-deoxy-d-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels (2001) Ann Surg Oncol, 8, pp. 779-786. , 11776491 10.1007/s10434-001-0779-9 1:STN:280:DC%2BD38%2FkvVynsw%3D%3D
Zervos, E.E., Badgwell, B.D., Burak, Jr.W.E., Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup (2001) Surgery, 130, pp. 636-643. , 11602894 10.1067/msy.2001.116919 1:STN:280:DC%2BD3Mrls1WhtQ%3D%3D
Smeets, P., Ham, H., Ceelen, W., Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data (2010) Q J Nucl Med Mol Imaging, 54, pp. 327-332. , 20639817 1:STN:280:DC%2BC3cnoslahsg%3D%3D
Simo, M., Lomena, F., Setoain, J., FDG-PET improves the management of patients with suspected recurrence of colorectal cancer (2002) Nucl Med Commun, 23, pp. 975-982. , 12352596 10.1097/00006231-200210000-00007 1:CAS:528:DC%2BD38XnsVarsrc%3D
Chua, T. C., Liauw, W., Chu, F., Viewing metastatic colorectal cancer as a curable chronic disease (2012) Am J Clin Oncol, 35, pp. 77-80. , 22257778 10. 1097/COC. 0b013e3181fe444
Shen, Y. Y., Liang, J. A., Chen, Y. K., Clinical impact of F-18-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan (2006) Hepatogastroenterology, 53, pp. 348-350. , 16795969
Dias, A. R., Nahas, S. C., Camargo, E. E., Recent evidences of the use of F-18-fluorodeoxyglucose positron emission tomography in the management of colorectal cancer (2007) J Surg Educ, 64, pp. 114-119. , 17462214 10. 1016/j. jsurg. 2006. 11. 004
Lu, Y. Y., Chen, J. H., Chien, C. R., Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: A systematic review and meta-analysis (2013) Int J Colorectal Dis, , Feb 14. [Epub ahead of print]
Kelley, R. K., Van Bebber, S. L., Phillips, K. A., Personalized medicine and oncology practice guidelines: A case study of contemporary biomarkers in colorectal cancer (2011) J Natl Compr Canc Netw, 9, pp. 13-25. , 21233242
Rockall, T. A., McDonald, P. J., Carcinoembryonic antigen: Its value in the follow-up of patients with colorectal cancer (1999) Int J Colorectal Dis, 14, pp. 73-77. , 10207736 10. 1007/s003840050188 1: STN: 280: DyaK1M3isVWnsQ%3D%3D
Brethauer, S. A., Magrino, T. J., Riffenburgh, R. H., Management of recurrent colorectal carcinoma (2002) Color Dis, 4, pp. 246-253. , 10. 1046/j. 1463-1318. 2002. 00327. x 10. 1046/j. 1463-1318. 2002. 00327. x
Mainenti, P. P., Iodice, D., Segreto, S., Colorectal cancer and 18FDG-PET/CT: What about adding the T to the N parameter in loco-regional staging? (2011) World J Gastroenterol, 17, pp. 1427-1433. , 21472100 10. 3748/wjg. v17. i11. 1427
Shreve, P. D., Anzai, Y., Wahl, R. L., Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants (1999) Radiographics, 19, pp. 61-77. , 9925392 10. 1148/radiographics. 19. 1. g99ja0761 1: STN: 280: DyaK1M7it1yjsw%3D%3D
Culverwell, A. D., Scarsbrook, A. F., Chowdhury, F. U., False-positive uptake on 2- [18F] -fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging (2011) Clin Radiol, 66, pp. 366-382. , 21356398 10. 1016/j. crad. 2010. 12. 004 1: STN: 280: DC%2BC3M3isFantg%3D%3D
Shihab, O. C., Taylor, F., Bees, N., Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer (2011) Brit J Surg, 98, pp. 1798-1804. , MERCURY Study Group 21928408 10. 1002/bjs. 7662 1: STN: 280: DC%2BC3MbksVOitw%3D%3D
Patel, U. B., Taylor, F., Blomqvist, L., Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience (2011) J Clin Oncol, 29, pp. 3753-3760. , 21876084 10. 1200/JCO. 2011. 34. 9068
Pilipshen, S. J., Heilweil, M., Quan, S. H., Patterns of pelvic recurrence following definitive resections of rectal cancer (1984) Cancer, 53, pp. 1354-1362. , 6692324 10. 1002/1097-0142 (19840315) 53: 6<1354: AID-CNCR2820530623>
3. 0. CO
2-J 1: STN: 280: DyaL2c7gs1ersA%3D%3D
Read, T. E., Mutch, M. G., Chang, B. W., Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon (2002) J Am Coll Surg, 195, pp. 33-40. , 12113543 10. 1016/S1072-7515 (02) 01224-3
Flanagan, F. L., Dehdashti, F., Ogunbiyi, O. A., Utility of FDGPET for investigating unexplained plasma CEA elevation in patients with colorectal cancer (1998) Ann Surg, 227, pp. 319-323. , 9527052 10. 1097/00000658-199803000-00001 1: STN: 280: DyaK1c7os1arsw%3D%3D
Libutti, S. K., Alexander, Jr. H. R., Choyke, P., A prospective study of 2- [F-18] fluoro-2-deoxy-d-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels (2001) Ann Surg Oncol, 8, pp. 779-786. , 11776491 10. 1007/s10434-001-0779-9 1: STN: 280: DC%2BD38%2FkvVynsw%3D%3D
Zervos, E. E., Badgwell, B. D., Burak, Jr. W. E., Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup (2001) Surgery, 130, pp. 636-643. , 11602894 10. 1067/msy. 2001. 116919 1: STN: 280: DC%2BD3Mrls1WhtQ%3D%3D
F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer